Skip to main content
. 2022 Nov 23;3(1):65–71. doi: 10.1016/j.jncc.2022.11.003

Fig. 1.

Fig 1

Progression-free survival (PFS) and overall survival (OS) evaluated using the Kaplan–Meier method before (A, B) and after (C, D) inverse-probability of treatment weighting analysis for overall corhorts. CRT, chemoradiation therapy; EGFR, epidermal growth factor receptor; RT, radiation therapy; TKI, tyrosine kinase inhibitor.